News from essa pharma inc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jun 21, 2019, 20:30 ET ESSA Pharma to Hold Annual Shareholders' Meeting and Announces Three Realm-Nominated Directors

HOUSTON, TX and VANCOUVER, June 21, 2019 /CNW/ - ESSA Pharma Inc. ("ESSA" or the "Company") (Nasdaq: EPIX; TSX-V: EPI), a pharmaceutical company focused on developing novel therapies for the...


May 16, 2019, 06:30 ET Agreement Reached for ESSA Pharma to Acquire Realm Therapeutics

Acquisition Expected to be Completed by Mid-Year 2019 VANCOUVER and HOUSTON, May 16, 2019 /CNW/ - ESSA Pharma Inc. ("ESSA" or "the Company") (NASDAQ: EPIX; TSX-V: EPI) announced today that it has...


May 10, 2019, 07:30 ET ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2019

HOUSTON, TX and VANCOUVER, May 10, 2019 /CNW/ - ESSA Pharma Inc. (TSX-V: EPI, NASDAQ: EPIX), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today ...


May 04, 2019, 16:00 ET Preclinical Data Highlighting Therapeutic Potential of EPI-7386 Presented at 2019 American Urological Association Annual Meeting

HOUSTON, TX and VANCOUVER, May 4, 2019 /CNW/ - ESSA Pharma Inc. (Nasdaq: EPIX; TSX-V: EPI), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today...


Apr 25, 2019, 07:30 ET ESSA Pharma to Attend Bloom Burton & Co. Healthcare Investor Conference 2019

HOUSTON and VANCOUVER, April 25, 2019 /CNW/ - ESSA Pharma Inc. (TSX-V: EPI; Nasdaq: EPIX) ("ESSA" or the "Company"), a pharmaceutical company focused on developing novel therapies for the treatment...


Apr 17, 2019, 07:30 ET ESSA Pharma Announces Abstract Presentation at the 2019 American Urological Association Annual Meeting

HOUSTON and VANCOUVER, April 17, 2019 /CNW/ - ESSA Pharma Inc. (TSX-V: EPI; Nasdaq: EPIX), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today...


Apr 12, 2019, 02:00 ET ESSA Pharma Grants Stock Options

HOUSTON, TX and VANCOUVER, April 12, 2019 /CNW/ - ESSA Pharma Inc. (TSX-V: EPI; Nasdaq: EPIX) ("ESSA" or the "Corporation") announced that, pursuant to its stock option plan, it has granted incentive ...


Mar 28, 2019, 17:02 ET ESSA Pharma Announces Upcoming Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2019

HOUSTON, TX and VANCOUVER, March 28, 2019 /CNW/ - ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI; Nasdaq: EPIX), a pharmaceutical company focused on developing novel therapies for the...


Mar 28, 2019, 17:01 ET ESSA Pharma Announces Nomination of EPI-7386 as Lead Clinical Candidate in Metastatic Castration-Resistant Prostate Cancer

HOUSTON and VANCOUVER, March 28, 2019 /CNW/ - ESSA Pharma Inc. (TSX-V: EPI; Nasdaq: EPIX), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today...


Mar 18, 2019, 07:30 ET ESSA Pharma to Present at the Oppenheimer 29th Annual Healthcare Conference

HOUSTON, TX and VANCOUVER, March 18, 2019 /CNW/ - ESSA Pharma Inc. (TSX-V: EPI; Nasdaq: EPIX) ("ESSA" or the "Company"), a pharmaceutical company focused on developing novel therapies for the...


Mar 14, 2019, 07:30 ET ESSA Pharma to Attend the 31st Annual ROTH Conference

HOUSTON and VANCOUVER, March 14, 2019 /CNW/ - ESSA Pharma Inc. (TSX-V: EPI; Nasdaq: EPIX) ("ESSA" or the "Company"), a pharmaceutical company focused on developing novel therapies for the treatment...


Feb 11, 2019, 07:30 ET ESSA Pharma Announces Two Abstracts Selected to be Presented at the 2019 Genitourinary Cancers Symposium

HOUSTON and VANCOUVER, Feb. 11, 2019 /CNW/ - ESSA Pharma Inc. (TSX-V: EPI; Nasdaq: EPIX) ("ESSA" or the "Company"), a pharmaceutical company focused on developing novel therapies for the treatment of ...


Feb 07, 2019, 17:05 ET ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2018

HOUSTON and VANCOUVER, Feb. 7, 2019 /CNW/ - ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI, NASDAQ: EPIX), a pharmaceutical company focused on developing novel therapies for the treatment of...


Dec 13, 2018, 17:02 ET ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2018

HOUSTON, TX and VANCOUVER, Dec. 13, 2018 /CNW/ - ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI, NASDAQ: EPIX), a pharmaceutical company focused on developing novel therapies for the...


Oct 22, 2018, 07:00 ET ESSA Appoints Otello Stampacchia, PH.D., of Omega Funds to Board of Directors

HOUSTON and VANCOUVER, Oct. 22, 2018 /CNW/ - ESSA Pharma Inc. (TSX-V: EPI, NASDAQ: EPIX) ("ESSA" or the "Company"), a pharmaceutical company focused on developing novel therapies for the treatment of ...


Aug 29, 2018, 07:00 ET ESSA Pharma to Present at 20th Annual Global Investment Conference In New York City September 4 - 6, 2018

HOUSTON and VANCOUVER, Aug. 29, 2018 /CNW/ - ESSA Pharma Inc. (TSX-V: EPIX, NASDAQ: EPIX) ("ESSA" or the "Company"), a pharmaceutical company focused on developing novel therapies for the treatment...


Aug 14, 2018, 07:00 ET ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2018

HOUSTON and VANCOUVER, Aug. 14, 2018 /CNW/ - ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI, NASDAQ: EPIX), a pharmaceutical company focused on developing novel therapies for the treatment of ...


May 14, 2018, 19:15 ET ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2018

HOUSTON and VANCOUVER, May 14, 2018 /CNW/ - ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI, NASDAQ: EPIX), a pharmaceutical company focused on developing novel therapies for the treatment of...


May 10, 2018, 17:05 ET Essa Pharma Inc. Regains Compliance with NASDAQ Listing Requirements

HOUSTON and VANCOUVER, May 10, 2018 /CNW/ - ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI, Nasdaq: EPIX), a pre-clinical stage pharmaceutical company focused on developing novel therapies...


Apr 26, 2018, 07:00 ET ESSA to present at Bloom Burton & Co. Healthcare Investor Conference 2018

HOUSTON and VANCOUVER, April 26, 2018 /CNW/ - ESSA Pharma Inc. (TSX-V: EPI, NASDAQ: EPIX) ("ESSA" or the "Company"), a pharmaceutical company focused on the development of novel small molecule drugs...


Apr 25, 2018, 07:00 ET ESSA Pharma Inc. Announces Completion of Share Consolidation

HOUSTON, TX and VANCOUVER, April 25, 2018 /CNW/ - ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI, NASDAQ: EPIX), a pre-clinical stage pharmaceutical company focused on developing novel...


Apr 24, 2018, 07:30 ET ESSA Pharma Enhances R&D Capabilities with Two New Key Hires

HOUSTON and VANCOUVER, April 24, 2018 /CNW/ - ESSA Pharma Inc. ("ESSA" or the "Company") (NASDAQ: EPIX, TSX-V: EPI), a pharmaceutical company focused on the development of novel small molecule drugs...


Apr 19, 2018, 19:38 ET ESSA Pharma Inc. Announces Share Consolidation

HOUSTON and VANCOUVER, April 19, 2018 /CNW/ - ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI, NASDAQ: EPIX), a pre-clinical stage pharmaceutical company focused on developing novel therapies...


Mar 28, 2018, 21:56 ET ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of Shareholders

HOUSTON and VANCOUVER, March 28, 2018 /CNW/ - ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI, NASDAQ: EPIX), a pre-clinical stage pharmaceutical company focused on developing novel therapies...


Feb 23, 2018, 09:02 ET ESSA Pharma Approves Stock Option Plan, RSU Plan, and Option Grants

HOUSTON and VANCOUVER, Feb. 23, 2018 /CNW/ - ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI, NASDAQ: EPIX), a pre-clinical stage pharmaceutical company focused on developing novel therapies...